The “AFP model” was superior to the traditional Milan criteria (i.e., morphologic-only criteria) in predicting HCC recurrence after liver transplantation and was adopted in 2013 by the French organization for Organ Sharing to select transplant candidates [24]. The gene discussed is AFP; the disease is hepatocellular carcinoma.